Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMLX | VERV | RCEL | ||
| Company | Amylyx Pharmaceuticals Inc | Verve Therapeutics Inc | Avita Medical Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.23 | 4.55 | 13.18 | ||
| High | 5.42 | 4.69 | 13.45 | ||
| Low | 4.98 | 4.44 | 12.58 | ||
| Last | 5.19 | 4.60 | 12.87 | ||
| Change | -0.04 | +0.05 | -0.18 | ||
| % Change | -0.76% | +1.10% | -1.38% | ||
| Volume | 1,889,300 | 1,398,100 | 121,800 | ||
| 20-Day Average Volume | 1,693,395 | 1,654,195 | 116,600 | ||
| Previous Close | 5.23 | 4.55 | 13.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.63 | 5.71 | 11.72 | ||
| 20-Day Raw Stochastic | 22.96% | 6.75% | 75.26% | ||
| 20-Day Relative Strength | 54.09% | 38.83% | 63.47% | ||
| Weighted Alpha | +114.82 | -61.76 | +53.11 | ||
| Today's Opinion | 64% Buy | 72% Sell | 72% Buy | ||
| Previous Opinion | 64% Buy | 72% Sell | 72% Buy | ||
| Last Month's Opinion | 40% Buy | 56% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.39% since 11/14/24 | -14.50% since 11/14/24 | +2.31% since 11/14/24 | ||
| Low | 4.57 on 11/15/24 | 4.44 on 11/21/24 | 11.63 on 11/18/24 | ||
| High | 5.88 on 11/18/24 | 5.44 on 11/15/24 | 13.82 on 11/20/24 | ||
| 1-Month | |||||
| %Chg | +11.37% since 10/21/24 | -17.12% since 10/21/24 | +22.34% since 10/21/24 | ||
| Low | 4.45 on 10/22/24 | 4.44 on 11/21/24 | 9.98 on 10/28/24 | ||
| High | 7.27 on 11/08/24 | 6.81 on 11/06/24 | 13.82 on 11/20/24 | ||
| 3-Month | |||||
| %Chg | +129.65% since 08/21/24 | -10.16% since 08/21/24 | +39.44% since 08/21/24 | ||
| Low | 2.05 on 08/28/24 | 4.37 on 10/10/24 | 8.22 on 09/04/24 | ||
| High | 7.27 on 11/08/24 | 6.81 on 11/06/24 | 13.82 on 11/20/24 | ||
| 6-Month | |||||
| %Chg | +188.33% since 05/21/24 | -16.97% since 05/21/24 | +58.11% since 05/21/24 | ||
| Low | 1.58 on 06/17/24 | 4.30 on 08/14/24 | 7.55 on 08/05/24 | ||
| High | 7.27 on 11/08/24 | 7.96 on 07/16/24 | 13.82 on 11/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 358,506 | 385,221 | 342,145 | ||
| Shares Outstanding, K | 68,548 | 84,664 | 26,218 | ||
| Annual Sales | 380,790,000 | 11,760,000 | 50,140,000 | ||
| Annual Net Income | 49,270,000 | -200,070,000 | -35,380,000 | ||
| Last Quarter Sales | 420,000 | 6,870,000 | 19,550,000 | ||
| Last Quarter Net Income | -72,700,000 | -50,130,000 | -16,210,000 | ||
| 60-Month Beta | -0.70 | 1.75 | 1.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.53 on 11/07/24 | -0.59 on 11/05/24 | -0.62 on 11/07/24 | ||
| Latest Earnings Date | 11/07/24 | 11/05/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 03/28/18 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||